Background
Increasing evidence exists that tumor volume may be a superior prognostic model than traditional TNM staging. It has been observed that OPSCC in the setting of human papillomavirus (HPV) positivity have a greater propensity for cystic nodal metastases, and thus presumably larger volume with relatively smaller primary tumors. The influence of HPV status on the predictive value of tumor volume is unknown.
Methods
Fifty-three patients with HPV-positive OPSCC were treated with definitive chemotherapy and intensity-modulated radiation therapy (IMRT).
Results
The estimated 2-year overall survival (OS) and disease-free survival (DFS) was 92.2% and 83.6%, respectively. Nodal classification did not predict OS (p=0.096) or DFS (p=0.170). Similarly, T classification did not predict OS (p=0.057) or DFS (p=0.309). Lower nodal volume was associated with greater DFS (p=0.001).
Conclusions
Nodal tumor volume was found to be predictive of DFS. DFS was best predicted by nodal gross tumor volume at 24 months.